Regression of Crizotinib-Associated Complex Cystic Lesions after Switching to Alectinib

Crizotinib, which is effective in patients with anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer, is sometimes associated with the generation of complex renal cysts. A 56-year-old man with ALK positive adenocarcinoma received crizotinib. Ten months after the introduction of crizo...

Descripción completa

Detalles Bibliográficos
Autores principales: Taima, Kageaki, Tanaka, Hisashi, Tanaka, Yoshihito, Itoga, Masamichi, Takanashi, Shingo, Tasaka, Sadatomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635307/
https://www.ncbi.nlm.nih.gov/pubmed/28794366
http://dx.doi.org/10.2169/internalmedicine.8445-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635307/
https://www.ncbi.nlm.nih.gov/pubmed/28794366
http://dx.doi.org/10.2169/internalmedicine.8445-16

Ejemplares similares